An efficient and fully automated high-throughput transfection method for genome-scale siRNA screens.
RNA interference (RNAi), combined with the availability of genome sequences, provides an unprecedented opportunity for the massive and parallel investigations of gene function. Small interfering RNA (siRNA) represents a popular and quick approach of RNAi for in vitro loss-of-function genetic screens. Efficient transfection of siRNA is critical for unambiguous interpretation of screen results and thus overall success of any siRNA screen. A high-throughput, lipid-based transfection method for siRNA was developed that can process eighty 384-well microplates in triplicate (for a total of 30,720 unique transfections) in 8 h. Transfection throughput was limited only by the speed of robotics, whereas the cost of screening was reduced. As a proof of principle, a genome-scale screen with a library of 22,108 siRNAs was performed to identify the genes sensitizing cells to mitomycin C at concentrations of 0, 20, and 60 nM. Transfection efficiency, performances of control siRNAs, and other quality metrics were monitored and demonstrated that the new, optimized transfection protocol produced high-quality results throughout the screen.
Chung
Namjin
N
Department of Automated Biotechnology, Merck Research Laboratories, North Wales, PA 19454, USA. namjin.chung@bms.com
Locco
Louis
L
Huff
Kevin W
KW
Bartz
Steven
S
Linsley
Peter S
PS
Ferrer
Marc
M
Strulovici
Berta
B
D000465:Algorithms; D001331:Automation; D004526:Efficiency; D020869:Gene Expression Profiling / Q000379:methods; D015894:Genome, Human / Q000187:drug effects; D006367:HeLa Cells; D006801:Humans; D034741:RNA, Small Interfering / Q000494:pharmacology*; D014162:Transfection / Q000295:instrumentation / Q000379:methods*
D034741:RNA, Small Interfering